Activation of ErbB3-PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas

Oncogene

Volumn 22, Issue 9, 2003, Pages 1294-1301

  Kobayashi, Michimoto ^a   Iwamatsu, Akihiro ^b   Shinohara Kanda, Azusa ^b   Ihara, Sayoko ^a   Fukui, Yasuhisa ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KIRIN BREWERY CO LTD   (Japan)

Author keywords

ErbB3; Gastric cancer; Mucin; Phosphatidylinositol 3 kinase; Signet ring cell carcinoma

Indexed keywords

CHIMERIC PROTEIN; MUCIN 1; NEU DIFFERENTIATION FACTOR; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; RECEPTOR; TUMOR MARKER; TYROSINE;

ADENOCARCINOMA; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL INTERACTION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE ERB B3; ONCOGENE NEU; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SIGNET RING CARCINOMA; STOMACH CANCER; TUMOR DIFFERENTIATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOCARCINOMA; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; CA-15-3 ANTIGEN; CARCINOMA, SIGNET RING CELL; CELL DIFFERENTIATION; CELL POLARITY; COLONIC NEOPLASMS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB; GENES, ERBB-2; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PHENOTYPE; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; RECOMBINANT FUSION PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STOMACH NEOPLASMS;

ANIMALIA;

EID: 0037422206     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206256     Document Type: Article

References (36)

1. Altiok N, Altiok S and Changeux JP. (1997). EMBOJ., 16, 717-725.
2. Burgering BM and Coffer PJ. (1995). Nature, 376, 599-602.
3. Chang HW, Aoki M, Fruman D, Auger KR, Bellacosa A, Tsichlis PN, Cantley LC, Roberts TM and Vogt PK. (1997). Science, 276, 1848-1850.
4. Chen X, Yeung TK and Wang Z. (2000). Biochem. Biophys. Res. Commun., 277, 757-763.
5. Guddo F, Giatromanolaki A, Patriarca C, Hilkens J, Reina C, Alfano RM, Vignola AM, Koukourakis MI, Gambacorta M, Pruneri G, Coggi G and Bonsignore G. (1998). Anticancer Res., 18, 1915-1920.
6. Guy PM, Platko JV, Cantley LC, Cerione RA and Carraway III KL. (1994). Proc. Natl Acad. Sci. USA, 91, 8132-8136.
7. Han J, Luby-Phelps K, Das B, Shu X, Xia Y, Mosteller RD, Krishna UM, Falck JR, White MA and Broek D. (1998). Science, 279, 558-560.
8. Hellyer NJ, Cheng K and Koland JG. (1998). Biochem. J., 333, 757-763.
9. Isogaki J, Shinmura K, Yin W, Arai T, Koda K, Kimura T, Kino I and Sugimura H. (1999). Cancer Detect. Prev., 23, 204-214.
10. Iwamatsu A and Yoshida-Kubomura N. (1996). J. Biochem., 120, 29-34.
11. Jensen ON, Podtelejnikov A and Mann M. (1996). Rapid Commun. Mass Spectrom., 10, 1371-1378.
12. Kanegae Y, Lee G, Sato Y, Tanaka M, Nakai M, Sakaki T, Sugano S and Saito I. (1995). Nucleic Acids Res., 23, 3816-3821.
13. Kim HH, Sierke SL and Koland JG. (1994). J. Biol. Chem., 269, 24747-24755.
14. Klippel A, Kavanaugh WM, Pot D and Williams LT. (1997). Mol. Cell. Biol., 17, 338-344.
15. Kobayashi M, Nagata S, Iwasaki T, Yanagihara K, Saitoh I, Karouji Y, Ihara S and Fukui Y. (1999). Proc. Natl. Acad. Sci. USA, 96, 4874-4879.
16. Komatsu M, Carraway CA, Fregien NL and Carraway KL. (1997). J. Biol. Chem., 272, 33245-33254.
17. Kondo K, Kohno N, Yokoyama A and Hiwada K. (1998). Cancer Res., 58, 2014-2019.
18. Kufe D, Inghirami G, Abe M, Hayes D, Justi-Wheeler H and Schlom J. (1984). Hybridoma, 3, 223-232.
19. Lavan BE, Kuhne MR, Garner CW, Anderson D, Reedijk M, Pawson T and Lienhard GE. (1992). J. Biol. Chem., 267, 11631-11636.
20. Levkowitz G, Klapper LN, Tzahar E, Freywald A, Sela M and Yarden Y. (1996). Oncogene, 12, 1117-1125.
21. Ma YY, Wei SJ, Lin YC, Lung JC, Chang TC, Whang-Peng J, Liu JM, Yang DM, Yang WK and Shen CY. (2000). Oncogene, 19, 2739-2744.
22. Maehama T and Dixon JE. (1998). J. Biol. Chem., 273, 13375-13378.
23. Peter MS, Eamonn DR, Robert DC and William JM. (1999). EMBOJ., 18, 2149.
24. Sakaguchi T, Watanabe A, Sawada H, Yamada Y, Yamashita J, Matsuda M, Nakajima M, Miwa T, Hirao T and Nakano H. (1998). Cancer, 82, 1238-1243.
25. Sander EE, van Delft S, ten Klooster JP, Reid T, van der Kammen RA, Michiels F and Collard JG. (1998). J. Cell Biol., 143, 1385-1398.
26. Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, Pinkel D, Powell B, Mills GB and Gray JW. (1999). Nat. Genet., 21, 99-102.
27. Soltoff SP, Carraway III KL, Prigent SA, Gullick WG and Cantley LC. (1994). Mol. Cell. Biol., 14, 3550-3558.
28. Tahara E. (1993). J. Cancer Res. Clin. Oncol., 119, 265-272.
29. Tanaka K, Adachi H, Konishi H, Iwamatsu A, Ohkawa K, Shirai T, Nagata S, Kikkawa U and Fukui Y. (1999). Biosci. Biotechnol. Biochem., 63, 368-372.
30. Tanaka S, Matsuda M, Nagata S, Kurata T, Nagashima K, Shizawa Y and Fukui Y. (1993). Jpn. J. Cancer Res., 84, 279-289.
31. Tokunaga A, Onda M, Okuda T, Teramoto T, Fujita I, Mizutani T, Kiyama T, Yoshiyuki T, Nishi K and Matsukura N. (1995). Cancer, 75, 1418-1425.
32. Wallasch C, Weiss FU, Niederfellner G, Jallal B, Issing W and Ullrich A. (1995). EMBO J., 14, 4267-4275.
33. Waterman H, Alroy I, Stano S, Seger R and Yarden Y. (1999). EMBO J., 18, 3348-3358.
34. Wongsasant B, Matsuda S and Yamamoto T. (1991). Biochem. Biophys. Res. Commun., 181, 981-988.
35. Yanagihara K and Tsumuraya M. (1992). Cancer Res., 52, 4042-4045.
36. Zhang K, Sun J, Liu N, Wen D, Chang D, Thomason A and Yoshinaga SK. (1996). J. Biol. Chem., 271, 3884-3890.